Ozempic

Ozempic is a brand name for the drug semaglutide, a prescription medication used to treat type 2 diabetes and, in some cases, to promote weight loss. It works by mimicking a hormone that helps regulate blood sugar and appetite.

Why it’s in the news: It is in the news due to its widespread use for weight loss, leading to cultural phenomena like 'Ozempic face,' its maker's competitive and cybersecurity challenges, and ongoing research into its potential longevity benefits.

Latest on Ozempic

• K-Beauty wants to fix the ‘Ozempic face’ problem
• South Korean biotech bets on donated human fat product to fix ‘Ozempic face’
• How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
• Are Ozempic and other weight loss drugs also longevity drugs? Here's what early research suggests
• Ozempic Maker Novo Nordisk Says Hackers Breached IT Systems

Connections

6 entities linked to Ozempic across the news graph.